Challenges and future perspectives of enhanced passive safety surveillance of influenza vaccines in Europe
Therapeutic Advances in Drug Safety
Published online on January 30, 2026
Abstract
Therapeutic Advances in Drug Safety, Volume 17, January-December 2026.
Postmarketing surveillance is critical for confirming the safety profile of vaccines following regulatory approval. This article contributes to the ongoing discussion on safety surveillance strategies for seasonal influenza vaccines in Europe. We examine ...
Postmarketing surveillance is critical for confirming the safety profile of vaccines following regulatory approval. This article contributes to the ongoing discussion on safety surveillance strategies for seasonal influenza vaccines in Europe. We examine ...